Erianin
Erianin, often used as an antipyretic and analgesic agent, could inhibit IDO-induced tumor angiogenesis.
Product Specifications
CAS Number
95041-90-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Erianin.html
Concentration
10mM
Purity
99.77
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC1=CC(CCC2=CC(OC)=C(OC)C(OC)=C2)=CC=C1OC
Molecular Formula
C18H22O5
Molecular Weight
318.36
Precautions
H302, H315, H319, H335
References & Citations
[1]Su C, et al. Erianin inhibits indoleamine 2, 3-dioxygenase -induced tumor angiogenesis. Biomed Pharmacother. 2017 Apr;88:521-528.|[2]Li M, et al. Erianin inhibits human cervical cancer cell through regulation of tumor protein p53 via the extracellular signal-regulated kinase signaling pathway. Oncol Lett. 2018 Oct;16 (4) :5006-5012.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941398-500 1x 500 µL
BRCA1 (Breast Marker) (BRCA1/1398), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
